Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels

INTRODUCTION: The lack of approved specific therapeutic agents to treat coronavirus disease (COVID‐19) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has led to the rapid implementation of convalescent plasma therapy (CPT) trials in many countries, including t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transfus Med
Hlavní autoři: Harvala, Heli, Robb, Matthew L., Watkins, Nick, Ijaz, Samreen, Dicks, Steven, Patel, Monika, Supasa, Piyada, Wanwisa, Dejnirattisai, Liu, Chang, Mongkolsapaya, Juthathip, Bown, Abbie, Bailey, Daniel, Vipond, Richard, Grayson, Nicholas, Temperton, Nigel, Gupta, Sunetra, Ploeg, Rutger J., Bolton, Jai, Fyfe, Alex, Gopal, Robin, Simmonds, Peter, Screaton, Gavin, Thompson, Craig, Brooks, Tim, Zambon, Maria, Miflin, Gail, Roberts, David J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246874/
https://ncbi.nlm.nih.gov/pubmed/33333627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tme.12746
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky